A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.


Updates from The Motley Fool

Latest updates on Bausch Health Companies from Fool.com.  The Fool has written over 400 articles on Bausch Health Companies.


Stock Performance

View Interactive BHC Charts
Sponsored by

Key Data Points

Primary metrics and data points about Bausch Health Companies.
Current Price: $24.26
Prev Close: $24.58
Open: $24.87
Bid: $24.25
Ask: $24.29
Day's Range: $24.20 - $25.27
52wk Range: $10.94 - $28.45
Volume: 3,435,066
Avg Vol 5,570,043
Market Cap: $8B
P/E (ttm): -5.24
EPS (ttm): -$4.69
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Bausch Health Companies.
CAPS Rating 2 out of 5
 
484 Outperform
72 Underperform
CAPS All Stars
 
81 Outperform
22 Underperform

How do you think Bausch Health Companies will perform against the market?



You pick for Bausch Health Companies is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Joseph C. Papa, CEO

87% Approve

Based on 9 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Bausch Health Companies.

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers